Infectious Disease Control APAC News & Press Release Distribution

Infectious Disease Control

All
Global

Novavax Prototype COVID-19 Vaccine Data Support Homologous and Heterologous Boosting and Suggest Benefit Against Variants

* Homologous boosting with the prototype Novavax COVID-19 vaccine induced robust antibody titers for Omicron BA.1, BA.2, and BA.5 * Study 307 (Lot Consistency) achieved its primary endpoint, showing that three vaccine lots induced a comparable immune response thereby demonstrating the consist...

2022-10-12 21:35 2397

Brii Biosciences Announces Top-line Results from Phase 1 Study of BRII-296, A Long-Acting Therapy in Development for Postpartum Depression

* Data demonstrated that a single administration of BRII-296 at 600 mg delivered a favorable pharmacokinetic profile and is safe and well-tolerated in healthy subjects * Findings suggest BRII-296 has potential to provide a safe and effective, one-time injectable treatment option to people wit...

2022-09-26 20:00 2430

Gates Foundation Announces $1.27 Billion in Health and Development Commitments to Advance Progress Toward the Global Goals

First in-person Goalkeepers event since 2019 convenes global changemakers to highlight the urgency of achieving a more equitable world by 2030 NEW YORK, Sept. 22, 2022 /PRNewswire/ -- During United Nations General Assembly week, the Bill & Melinda Gates Foundation—alongside governments, philanth...

2022-09-22 06:36 1844

MGC Pharmaceuticals Successfully Developed Herbal-inspired Products for Treatment of Long COVID and COVID-19

LONDON, Sept. 21, 2022 /PRNewswire/ -- MGC Pharmaceuticals Ltd. (LSE: MXC), (ASX: MXC), (OTC: MGCLF), is a European based bio-pharma company, focused on developing and supplying affordable (Accessible) and Ethically Produced Plant Inspired Medicines, is helping to solve the mystery of treating Lo...

2022-09-21 17:13 3116

Menarini and SciClone Sign Exclusive Licensing Agreement to Develop and Commercialize Vaborem® in China to Treat Antimicrobial Resistant Infections

* Vaborem®, a patented combination of meropenem and vaborbactam, is expected to address the rising prevalence of carbapenem-resistant Klebsiella pneumoniae (CRKP) infections inChina * The deal brings together Melinta's innovation, Menarini's cross-regional expertise in registration and market...

2022-09-20 17:00 2493

Apex Circuit (Thailand) Co., Ltd. Awarded at the Asia Responsible Enterprise Awards 2022 for 'Vaccine 100' under Health Promotion Category

SINGAPORE, Sept. 15, 2022 /PRNewswire/ -- The Asia Responsible Enterprise Awards (AREA) 2022 is pleased to honor 72 exemplary award recipients for championing ESG to build a resilient world and a sustainable future for all. The AREA is the most prominent CSR recognition program across Asia initia...

2022-09-15 16:48 2248

GILEAD SCIENCES CELEBRATES TOP RANKING BY HEPATITIS & ASIAN PATIENT GROUPS

-- In the recently published PatientView report, Gilead is ranked number one in all corporate reputation indicators by hepatitis patient groups globally -- -- Gilead also ranks first among peers in Asia by patient groups in this region -- HONG KONG, Sept. 15, 2022 /PRNewswire/ -- Gilead Sciences...

2022-09-15 10:00 2054

TikoMed's ILB(R) inhibits cell infection by coronaviruses and modulates reactive cytokine release from microglia in vitro

Adds further support for its broad-spectrum mechanism of action following other recent TBI, ALS and tropical virus studies VIKEN, Sweden, Sept. 13, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study evaluating the ability of the company's lead drug candid...

2022-09-13 16:08 1677

German Chancellor Scholz, WHO Director-General Tedros, international ministers at World Health Summit 2022

Press accreditation open for the world's leading global health conference BERLIN, Sept. 13, 2022 /PRNewswire/ -- The World Health Summit and the World Health Organization (WHO) as co-organizer jointly invite to the world's leading global health conference. The World Health Summit 2022 fromOctober...

2022-09-13 15:50 1344

Aldatu Biosciences Adds Another Outbreak Disease to Pandemic Preparedness Portfolio

BOSTON, Sept. 13, 2022 /PRNewswire/ -- Aldatu Biosciences, a biotechnology company developing molecular diagnostic assays and products based on gold standard real-time PCR, today announced it has been awarded a$3 Million Direct-to-Phase II Small Business Innovation Research (SBIR) grant from the ...

2022-09-13 00:33 1555

The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies

Innovations triggered by the pandemic are pushing industries to adopt long-lasting antimicrobial technology, says Frost & Sullivan SAN ANTONIO, Sept. 8, 2022 /PRNewswire/ -- The outbreak of COVID-19 unlocked the demand for antimicrobial technologies across sectors, finds Frost & Sullivan's recen...

2022-09-08 15:12 1718

The Outbreak of COVID-19 Unlocked the Demand for Antimicrobial Technologies

TikoMed's drug candidate ILB® inhibited infection of human cells by Dengue, Zika and Yellow Fever viruses in vitro, providing further support for its broad spectrum mechanism of action

VIKEN, Sweden, Sept. 7, 2022 /PRNewswire/ -- TikoMed today announced the inclusion in bioRxiv* of an in vitro study examining the ability of the company's lead drug candidate ILB® to inhibit infection of human cells by four serotypes of Dengue virus (DENV1-4), two strains of Zika virus (African a...

2022-09-07 14:32 2791

Brii Biosciences Appoints Taiyin Yang to Board of Directors, Strengthening Product Quality Oversight to Support Company Momentum

Addition increases diversity of Board governance and supports further independent expertise DURHAM, N.C. and BEIJING, Sept. 1, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock code: 2137.HK), a multi-national company developing...

2022-09-01 07:30 2768

NIAID/NIH recognizes the potency of UB-421 against multi-drug resistant HIV and receives the FDA approval to conduct a phase 2 clinical trial with UB-421

TAIPEI, Aug. 31, 2022 /PRNewswire/ -- United BioPharma (UBP) announced today that the U.S. Food and Drug Administration (FDA) has approved a phase 2 clinical trial IND submitted by the U.S. National Institute of Allergy and Infectious Diseases (NIAID) of NIH. The purpose of this study is to asses...

2022-08-31 12:24 1804

New report highlights the technology key to fighting future pandemics

MELBOURNE, Australia, Aug. 30, 2022 /PRNewswire/ -- CSIRO, Australia's national science agency, has outlined the science and technology that can help improve resilience to future pandemics, reduce their economic impact and protect communities. The Strengthening Australia's Pandemic Preparedness ...

2022-08-30 04:00 3482

AQUILAVIE LAUNCHES SAFE AND PAINLESS 'AQ LOLLIPOP' DUAL-USE COVID-19 RAPID TEST KIT FOR KIDS IN DISCOUNTED BACK-TO-SCHOOL BUNDLE

Hong Kong-based PPE and Medical Device Specialist Launches a Groundbreaking New, Safe, Easy and Effective Alternative Solution for Parents and Children Faced with Daily Testing in the New School Year HONG KONG, Aug. 29, 2022 /PRNewswire/ -- AQUILAVIE® launches its newest consumer product, t...

2022-08-29 14:00 2580

AQUILAVIE LAUNCHES SAFE AND PAINLESS 'AQ LOLLIPOP' DUAL-USE COVID-19 RAPID TEST KIT FOR KIDS IN DISCOUNTED BACK-TO-SCHOOL BUNDLE

Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results

Additions to executive team strengthen global leadership and position Company for strategic long-term growth First-ever product launch of long-acting amubarvimab/romlusevimab combination therapy for COVID-19 inChina advances Brii Bio from clinical development to commercial stage biotechnology co...

2022-08-24 07:30 3887

Brii Biosciences Provides Corporate Update and Reports 2022 Interim Results

Brii Biosciences Appoints Eleanor de Groot as Chief Technology Officer and Aleksandar Skuban as Central Nervous System Diseases Therapy Area Head

Building a leadership team with global and local experience and expertise to enable rapid execution across Company's broad therapeutic strategy DURHAM, N.C. and BEIJING, Aug. 23, 2022 /PRNewswire/ -- Brii Biosciences Limited ("Brii Bio" or the "Company", stock ...

2022-08-23 07:30 3485

U.S. FDA Grants Emergency Use Authorization for Novavax COVID-19 Vaccine, Adjuvanted for Adolescents Aged 12 Through 17

* Novavax' vaccine is the first protein-based COVID-19 vaccine authorized in the U.S. * Doses of the Novavax COVID-19 Vaccine, Adjuvanted are now available and primary series immunizations for adolescents can beginonce a policy recommendation from the CDC is received GAITHERSBURG, Md., Aug. 2...

2022-08-22 10:05 3481

Ascletis Announces IND Approval of Oral RdRp Inhibitor ASC10 for COVID-19 by China NMPA

-- Ascletis is China's first biotech company which has obtained IND approvals of an oral RdRp inhibitor from both China NMPA and the U.S. FDA -- Ascletis has filed multiple patent applications for ASC10 and its use globally. Compared with molnupiravir, ASC10 has a new and differentiated chemical...

2022-08-22 08:10 2686

1 ... 6 7 8910 11 12 ... 66